Investors have queried Yinghe Technology if their e-cigarette brand, Sikary, is experiencing explosive growth in the United Kingdom.
On August 1st, the company responded by stating that in order to seize further opportunities in the European market and expedite the TPD certification process for new e-cigarette products, as well as to promptly address customer pre-sales and after-sales service needs, the board of directors has approved the establishment of a wholly-owned subsidiary in the United Kingdom by the name of "SKE". Scoler has shown favorable progress in expanding its operations in the UK region.
According to a previous report, based on the announcement by Shenzhen YInghe Technology Co., Ltd. (hereafter referred to as "the company") regarding its subsidiary's investment in establishing a subsidiary in the United Kingdom, SKE will establish a wholly-owned subsidiary in Manchester, England, with a registered capital of 250,000 pounds (317,000 USD), focusing on the UK and European markets.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
